Search research articles
Contact Us
Filters
Showing results (81-90 of 296) with videos related to
Page
of 30
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 3, 2022
Understanding Interindividual Variability in the Drug Interaction of a Highly Extracted CYP1A2 Substrate Tizanidine: Application of a Permeability-Limited Multicompartment Liver Model in a Population Based Physiologically Based Pharmacokinetic Framework
Mian Zhang, Ciarán Fisher, Iain Gardner, et al.
The Journal of Clinical Investigation
|
May 27, 2015
Mediation of opioid analgesia by a truncated 6-transmembrane GPCR
Zhigang Lu, Jin Xu, Grace C Rossi, et al.
Synapse (New York, N.Y.)
|
December 31, 2013
Isolating and characterizing three alternatively spliced mu opioid receptor variants: mMOR-1A, mMOR-1O, and mMOR-1P
Jin Xu, Mingming Xu, Elizabeth Bolan, et al.
Hematology/Oncology Clinics of North America
|
May 7, 2021
Preclinical Models for Bladder Cancer Research
Shaoming Zhu, Zheng Zhu, Ai-Hong Ma, et al.
Cellular and Molecular Neurobiology
|
October 9, 2020
Mu Opioids Induce Biased Signaling at the Full-Length Seven Transmembrane C-Terminal Splice Variants of the mu Opioid Receptor Gene, Oprm1
Ankita Narayan, Amanda Hunkele, Jin Xu, et al.
Molecular Pharmacology
|
June 9, 2005
Identification of four novel exon 5 splice variants of the mouse mu-opioid receptor gene: functional consequences of C-terminal splicing
Ying-Xian Pan, Jin Xu, Elizabeth Bolan, et al.
Brain, Behavior, and Immunity
|
April 10, 2020
Sex-dependent effects of GPER activation on neuroinflammation in a rat model of traumatic brain injury
Meng-Xian Pan, Jie Li, Chao Ma, et al.
Cancer
|
June 29, 2004
Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder
Liang Cheng, Gregory T MacLennan, Shaobo Zhang, et al.
International Journal of Cancer
|
June 25, 2011
MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status
Ruth L Vinall, Alexandra Z Ripoll, Sisi Wang, et al.
Clinical Pharmacology and Therapeutics
|
January 14, 2025
Cytokine Dynamics in Action: A Mechanistic Approach to Assess Interleukin 6 Related Therapeutic Protein-Drug-Disease Interactions
Xian Pan, Katherine L Gill, Amita Pansari, et al.
Page
of 30
Search research articles
Search
Showing results (81-90 of 296) with videos related to
Sort By:
Page
of 30
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 3, 2022
Understanding Interindividual Variability in the Drug Interaction of a Highly Extracted CYP1A2 Substrate Tizanidine: Application of a Permeability-Limited Multicompartment Liver Model in a Population Based Physiologically Based Pharmacokinetic Framework
Mian Zhang, Ciarán Fisher, Iain Gardner, et al.
The Journal of Clinical Investigation
|
May 27, 2015
Mediation of opioid analgesia by a truncated 6-transmembrane GPCR
Zhigang Lu, Jin Xu, Grace C Rossi, et al.
Synapse (New York, N.Y.)
|
December 31, 2013
Isolating and characterizing three alternatively spliced mu opioid receptor variants: mMOR-1A, mMOR-1O, and mMOR-1P
Jin Xu, Mingming Xu, Elizabeth Bolan, et al.
Hematology/Oncology Clinics of North America
|
May 7, 2021
Preclinical Models for Bladder Cancer Research
Shaoming Zhu, Zheng Zhu, Ai-Hong Ma, et al.
Cellular and Molecular Neurobiology
|
October 9, 2020
Mu Opioids Induce Biased Signaling at the Full-Length Seven Transmembrane C-Terminal Splice Variants of the mu Opioid Receptor Gene, Oprm1
Ankita Narayan, Amanda Hunkele, Jin Xu, et al.
Molecular Pharmacology
|
June 9, 2005
Identification of four novel exon 5 splice variants of the mouse mu-opioid receptor gene: functional consequences of C-terminal splicing
Ying-Xian Pan, Jin Xu, Elizabeth Bolan, et al.
Brain, Behavior, and Immunity
|
April 10, 2020
Sex-dependent effects of GPER activation on neuroinflammation in a rat model of traumatic brain injury
Meng-Xian Pan, Jie Li, Chao Ma, et al.
Cancer
|
June 29, 2004
Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder
Liang Cheng, Gregory T MacLennan, Shaobo Zhang, et al.
International Journal of Cancer
|
June 25, 2011
MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status
Ruth L Vinall, Alexandra Z Ripoll, Sisi Wang, et al.
Clinical Pharmacology and Therapeutics
|
January 14, 2025
Cytokine Dynamics in Action: A Mechanistic Approach to Assess Interleukin 6 Related Therapeutic Protein-Drug-Disease Interactions
Xian Pan, Katherine L Gill, Amita Pansari, et al.
Page
of 30